Perspectives
Provider intervention associated with usage decline of high risk meds
Intervention impacts use of high-risk drugs in CMS Star metric
September 21, 2017Intervention designed to impact use of high-risk medications evaluated as part of CMS Star metric
Prime sent letters to doctors to let them know they had prescribed high-risk medications to Medicare members. The intervention group’s high-risk medication percentage declined more than the control group. It was a statistically significant difference. Certain medications carry a greater risk of adverse events for the older adults than for younger people. Safer options exist for many high-risk medications.
Related news
Perspectives
March 24, 2023
Look for Prime + Magellan Rx at AMCP 2023
Dr. Prerak Parikh (far left) and Dr. Sneha Sharma (far right) discuss trends…
Perspectives
March 23, 2023
Top female finance executive encourages DEI narrative
Over the past 30 years women’s careers in finance have seen significant progress,…
Perspectives
March 21, 2023
Top 10 acronyms in drug pipeline content, Part 2
News about biosimilars is everywhere. Sometimes you just need the basics. This four-part…